The mutant version of the tumor suppressor p53, which is mutated in 50% of cancers, drives invasion through enhanced Rab coupling protein (RCP)–dependent recycling of α5β1, the main receptor for FN, and several RTKs, EGFR, and Met (Caswell et al., 2008; Muller et al., 2013).